MEI is developing procedure-specific RF surgical tools for nearly bloodless treatment of liver cancer, kidney cancer and uterine fibroids.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free